Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Target Indication
Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
Clinical Trial
NCT02983799Last updated: 1/14/2026